CCL

Összesen 7 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM091508
035-os BibID:(cikkazonosító)1638 (scopus)85100498628 (wos)000623747200001
Első szerző:Fidrus Eszter (biotechnológus)
Cím:Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis - an In Vitro Study / Eszter Fidrus, Csaba Hegedűs, Eszter Anna Janka, György Paragh, Gabriella Emri, Éva Remenyik
Dátum:2021
ISSN:1661-6596 1422-0067
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:International Journal Of Molecular Sciences. - 22 : 4 (2021), p. 1-17. -
További szerzők:Hegedűs Csaba (1988-) (molekuláris biológus) Janka Eszter Anna (1989-) (bőrgyógyász, népegészségügyi szakember) Paragh György (1953-) (belgyógyász) Emri Gabriella (1972-) (bőrgyógyász, allergológus, onkológus) Remenyik Éva (1956-) (bőrgyógyász)
Pályázati támogatás:GINOP-2.3.2-15-2016-00005
GINOP
K120206
OTKA
ÚNKP-20-4-I
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM115431
035-os BibID:(cikkazonosító)15308 (WoS)001091853400001 (Scopus)85175252490
Első szerző:Juhász Lilla (általános orvos)
Cím:Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions / Lilla Juhász, Hajnalka Lőrincz, Anita Szentpéteri, Nóra Tóth, Éva Varga, György Paragh, Mariann Harangi
Dátum:2023
ISSN:1422-0067
Megjegyzések:Stromal cell-derived factor-1 (SDF-1) is a chemokine that exerts multifaceted roles in atherosclerosis. However, its association with hyperlipidemia is contradictory. To date, serum SDF-1 and its correlations with lipid fractions and subfractions in heterozygous familial hypercholesterolemia (HeFH) have not been investigated. Eighty-one untreated patients with HeFH and 32 healthy control subjects were enrolled in the study. Serum SDF-1, oxidized LDL (oxLDL) and myeloperoxidase (MPO) were determined by ELISA. Lipoprotein subfractions were detected by Lipoprint. We diagnosed FH using the Dutch Lipid Clinic Network criteria. Significantly lower serum SDF-1 was found in HeFH patients compared to healthy controls. Significant negative correlations were detected between serum total cholesterol, triglycerides, LDL-cholesterol (LDL-C), apolipoprotein B100 (ApoB100) and SDF-1. Furthermore, serum SDF-1 negatively correlated with VLDL and IDL, as well as large LDL and large and intermediate HDL subfractions, while there was a positive correlation between mean LDL-size, small HDL and SDF-1. SDF-1 negatively correlated with oxLDL and MPO. A backward stepwise multiple regression analysis showed that the best predictors of serum SDF-1 were VLDL and oxLDL. The strong correlation of SDF-1 with lipid fractions and subfractions highlights the potential common pathways of SDF-1 and lipoprotein metabolism, which supports the role of SDF-1 in atherogenesis.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
stromal cell-derived factor-1
familial hypercholesterolemia
oxidized low-density lipoprotein
very low-density lipoprotein
large low-density lipoprotein
vascular repair
Megjelenés:International Journal Of Molecular Sciences. - 24 : 20 (2023), p. 1-14. -
További szerzők:Lőrincz Hajnalka (1986-) (biológus) Szentpéteri Anita (1988-) (biológus) Tóth Nóra (1994-) (orvos) Varga Éva (1982-) (belgyógyász) Paragh György (1953-) (belgyógyász) Harangi Mariann (1974-) (belgyógyász, endokrinológus)
Pályázati támogatás:142273
OTKA
TKP2021-EGA-18
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM105181
035-os BibID:(cikkazonosító)14065 (WOS)000887302300001 (Scopus)85142806190
Első szerző:Juhász Lilla (általános orvos)
Cím:Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia / Juhász Lilla, Lőrincz Hajnalka, Szentpéteri Anita, Nádró Bíborka, Varga Éva, Paragh György, Harangi Mariann
Dátum:2022
ISSN:1422-0067
Megjegyzések:High-density lipoprotein (HDL)-bound apolipoprotein M/sphingosine 1-phosphate (ApoM/S1P) complex in cardiovascular diseases serves as a bridge between HDL and endothe lial cells, maintaining a healthy endothelial barrier. To date, S1P and ApoM in patients with untreated heterozygous familial hypercholesterolemia (HeFH) have not been extensively studied. Eighty-one untreated patients with HeFH and 32 healthy control subjects were included in this study. Serum S1P, ApoM, sCD40L, sICAM-1, sVCAM-1, oxLDL, and TNF? concentrations were determined by ELISA. PON1 activities were measured spectrophotometrically. Lipoprotein subfractions were detected by Lipoprint. We diagnosed FH using the Dutch Lipid Clinic Network criteria. Significantly higher serum S1P and ApoM levels were found in HeFH patients compared to controls. S1P negatively correlated with large HDL and positively with small HDL subfractions in HeFH patients and the whole study population. S1P showed significant positive correlations with sCD40L and MMP-9 levels and PON1 arylesterase activity, while we found significant negative correlation between sVCAM-1 and S1P in HeFH patients. A backward stepwise multiple regression analysis showed that the best predictors of serum S1P were large HDL subfraction and arylesterase activity. Higher S1P and ApoM levels and their correlations with HDL subfractions and inflammatory markers in HeFH patients implied their possible role in endothelial protection.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
sphingosine 1-phosphate
familial hypercholesterolemia
sCD40 ligand
apolipoprotein M
soluble vascular adhesion molecule-1
arylesterase activity
high-density lipoprotein
inflammation
Megjelenés:International Journal Of Molecular Sciences. - 23 (2022), p. 1-12. -
További szerzők:Lőrincz Hajnalka (1986-) (biológus) Szentpéteri Anita (1988-) (biológus) Nádró Bíborka (1992-) (általános orvos) Varga Éva (1982-) (belgyógyász) Paragh György (1953-) (belgyógyász) Harangi Mariann (1974-) (belgyógyász, endokrinológus)
Pályázati támogatás:OTKA-142273
OTKA
TKP2021-EGA-18
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM116322
035-os BibID:(cikkazonosító)16504 (WOS)001113721200001 (Scopus)85177740392
Első szerző:Lőrincz Hajnalka (biológus)
Cím:Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients / Hajnalka Lőrincz, Sára Csiha, Balázs Ratku, Sándor Somodi, Ferenc Sztanek, Ildikó Seres, György Paragh, Mariann Harangi
Dátum:2023
ISSN:1422-0067
Megjegyzések:Betatrophin, also known as angiopoietin-like protein 8 (ANGPTL8), mainly plays a role in lipid metabolism. To date, associations between betatrophin and lipoprotein subfractions are poorly investigated. For this study, 50 obese patients with type 2 diabetes (T2D) and 70 nondiabetic obese (NDO) subjects matched in gender, age, and body mass index (BMI) as well as 49 gender- and age-matched healthy, normal-weight controls were enrolled. Serum betatrophin levels were measured with ELISA, and lipoprotein subfractions were analyzed using Lipoprint gel electrophoresis. Betatrophin concentrations were found to be significantly higher in the T2D and NDO groups compared to the controls in all subjects and in females, but not in males. We found significant positive correlations between triglyceride, very low density lipoprotein (VLDL), large LDL (low density lipoprotein), small LDL, high density lipoprotein (HDL) -6-10 subfractions, and betatrophin, while negative correlations were detected between betatrophin and IDL, mean LDL size, and HDL-1-5. Proportion of small HDL was the best predictor of betatrophin in all subjects. Small LDL and large HDL subfractions were found to be the best predictors in females, while in males, VLDL was found to be the best predictor of betatrophin. Our results underline the significance of serum betatrophin measurement in the cardiovascular risk assessment of obese patients with and without T2D, but gender differences might be taken into consideration.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
betatrophin
angiopoietin-like protein 8
triglyceride
lipoprotein subfractions
high-density lipoprotein
diabetes
obesity
Megjelenés:International Journal Of Molecular Sciences. - 24 : 22 (2023), p. 1-13. -
További szerzők:Csiha Sára (1985-) (Biológus) Ratku Balázs (1985-) (mentőtiszt) Somodi Sándor (1977-) (belgyógyász) Sztanek Ferenc (1982-) (orvos) Seres Ildikó (1954-) (biokémikus) Paragh György (1953-) (belgyógyász) Harangi Mariann (1974-) (belgyógyász, endokrinológus)
Pályázati támogatás:K142273
OTKA
PD146136
OTKA
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:BIBFORM108875
035-os BibID:(cikkazonosító)4115 (Scopus)85149053802 (WoS)000945033100001
Első szerző:Lőrincz Hajnalka (biológus)
Cím:Impaired Organokine Regulation in Non-Diabetic Obese Subjects : halfway to the Cardiometabolic Danger Zone / Hajnalka Lőrincz, Balázs Ratku, Sára Csiha, Ildikó Seres, Zoltán Szabó, György Paragh, Mariann Harangi, Sándor Somodi
Dátum:2023
ISSN:1422-0067
Megjegyzések:Altered organokine expression contributes to increased cardiometabolic risk in obesity. Our aim was to evaluate the associations of serum afamin with glucose homeostasis, atherogenic dyslipidemia, and other adipokines in severe obesity to clarify the early metabolic alterations. 106 non diabetic obese (NDO) subjects and 62 obese patients with type 2 diabetes matched for age, gender, and body mass index (BMI) were enrolled in this study. We compared their data with 49 healthy, lean controls. Serum afamin and retinol-binding protein 4 (RBP4), as well as plasma plasminogen activator inhibitor-1 (PAI-1), were measured with ELISA, and lipoprotein subfractions were analyzed using Lipoprint gel electrophoresis. Afamin and PAI-1 found to be significantly higher in the NDO and T2M group (p < 0.001 and p < 0.001, respectively) than in the controls. In contrast, RBP4 was unexpectedly lower in the NDO and T2DM group compared to controls (p < 0.001). Afamin showed negative correlations with mean LDL size and RBP4, but positive correlations with anthropometric, glucose/lipid parameters, and PAI-1 in both the overall patients and the in NDO + T2DM groups. BMI, glucose, intermediate HDL, and small HDL were predictors of afamin. Afamin may serve as a biomarker for the severity of cardiometabolic disturbances in obesity. The complexity of organokine patterns in NDO subjects draws attention to the diverse spectrum of obesity-related comorbidities.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
obesity
type 2 diabetes
insulin resistance
afamin
plasminogen-activator inhibitor-1
retinol binding protein 4
lipid metabolism
lipoprotein subfraction
cardiometabolic
Megjelenés:International Journal Of Molecular Sciences. - 24 : 4 (2023), p. 1-13. -
További szerzők:Ratku Balázs (1985-) (mentőtiszt) Csiha Sára (1985-) (Biológus) Seres Ildikó (1954-) (biokémikus) Szabó Zoltán (1973-) (belgyógyász, kardiológus) Paragh György (1953-) (belgyógyász) Harangi Mariann (1974-) (belgyógyász, endokrinológus) Somodi Sándor (1977-) (belgyógyász)
Pályázati támogatás:PD124126
OTKA
K142273
OTKA
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

6.

001-es BibID:BIBFORM114677
035-os BibID:(cikkazonosító)10281 (scopus)85164039480 (wos)001015071200001
Első szerző:Pikó Péter (biológus)
Cím:Association of CETP Gene Polymorphisms and Haplotypes with Cardiovascular Risk / Piko Peter, Jenei Tibor, Kosa Zsigmond, Sandor Janos, Kovacs Nora, Seres Ildiko, Paragh Gyorgy, Adany Roza
Dátum:2023
ISSN:1422-0067
Megjegyzések:Cholesteryl ester transfer protein (CETP) is known to influence HDL-C levels, potentially altering the profile of HDL subfractions and consequently cardiovascular risk (CVR). This study aimed to investigate the effect of five single-nucleotide polymorphisms (SNPs; rs1532624, rs5882, rs708272, rs7499892, and rs9989419) and their haplotypes (H) in the CETP gene on 10-year CVR estimated by the Systematic Coronary Risk Evaluation (SCORE), the Framingham Risk Score for Coronary Heart Disease (FRSCHD) and Cardiovascular Disease (FRSCVD) algorithms. Adjusted linear and logistic regression analyses were used to investigate the association of SNPs and 10 haplotypes (H1-H10) on 368 samples from the Hungarian general and Roma populations. The T allele of rs7499892 showed a significant association with increased CVR estimated by FRS. H5, H7, and H8 showed a significant association with increased CVR based on at least one of the algorithms. The impact of H5 was due to its effect on TG and HDL-C levels, while H7 showed a significant association with FRSCHD and H8 with FRSCVD mediated by a mechanism affecting neither TG nor HDL-C levels. Our results suggest that polymorphisms in the CETP gene may have a significant effect on CVR and that this is not mediated exclusively by their effect on TG and HDL-C levels but also by presently unknown mechanisms.
Tárgyszavak:Orvostudományok Egészségtudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Framingham Risk Score
HDL subfraction profile
Systematic Coronary Risk Evaluation
cholesteryl ester transfer protein
haplotype
high-density lipoprotein cholesterol
single-nucleotide polymorphism
Megjelenés:International Journal Of Molecular Sciences. - 24 : 12 (2023), p. 1-16. -
További szerzők:Jenei Tibor (1963-) (programtervező informatikus) Kósa Zsigmond (1953-) (orvos) Sándor János (1966-) (orvos-epidemiológus) Kovács Nóra (1989-) (népegészségügyi szakember) Seres Ildikó (1954-) (biokémikus) Paragh György (1953-) (belgyógyász) Ádány Róza (1952-) (megelőző orvostan és népegészségtan szakorvos)
Pályázati támogatás:GINOP-2.3.2-15-2016-00005
GINOP
135784
OTKA
TK2016-78
Egyéb
TKCS-2021/32
Egyéb
ÚNKP-22-4-II-DE-268
Egyéb
RRF-2.3.1-21-2022-00006
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

7.

001-es BibID:BIBFORM114678
035-os BibID:(cikkazonosító)13563 (scopus)85170209245 (wos)001060602800001
Első szerző:Pikó Péter (biológus)
Cím:Association of HDL Subfraction Profile with the Progression of Insulin Resistance / Piko Peter, Jenei Tibor, Kosa Zsigmond, Sandor Janos, Kovacs Nora, Seres Ildiko, Paragh Gyorgy, Adany Roza
Dátum:2023
ISSN:1422-0067
Megjegyzések:Type 2 diabetes mellitus (T2DM) is a major global public health problem, as it is associated with increased morbidity, mortality, and healthcare costs. Insulin resistance (IR) is a condition characterized by disturbances in carbohydrate and lipid metabolism that precedes T2DM. The aim of the present study was to investigate the association between HDL and its subfraction profile and the progression of IR, as assessed by the Homeostatic Model Assessment for IR (HOMA-IR) index, and to define cut-off values to identify an increased risk of IR. Individuals with a HOMA-IR greater than 3.63 were considered to have IR. The HDL subfractions were separated using the Lipoprint system, which identifies ten subfractions (HDL-1-10) in three subclasses as large (HDL-L), intermediate (HDL-I) and small (HDL-S). Analyses were performed on samples from 240 individuals without IR and 137 with IR from the Hungarian general and Roma populations. The HDL-1 to -6 subfractions and the HDL-L and -I classes showed a significant negative association with the progression and existence of IR. Among them, HDL-2 (B = -40.37, p = 2.08 ? 10-11) and HDL-L (B = -14.85, p = 9.52 ? 10-10) showed the strongest correlation. The optimal threshold was found to be 0.264 mmol/L for HDL-L and 0.102 mmol/L and above for HDL-2. Individuals with HDL-L levels below the reference value had a 5.1-fold higher risk of IR (p = 2.2 ? 10-7), while those with HDL-2 levels had a 4.2-fold higher risk (p = 3.0 ? 10-6). This study demonstrates that the HDL subfraction profile (especially the decrease in HDL-2 and -L) may be a useful marker for the early detection and intervention of atherogenic dyslipidemia in subjects with impaired glucose and insulin metabolism.
Tárgyszavak:Orvostudományok Egészségtudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
insulin resistance
HDL subfraction profile
HDL-2
large HDL
cut-off points
HOMA-IR
diabetes
high-density lipoprotein cholesterol
Megjelenés:International Journal Of Molecular Sciences. - 24 : 17 (2023), p. 1-13. -
További szerzők:Jenei Tibor (1963-) (programtervező informatikus) Kósa Zsigmond (1953-) (orvos) Sándor János (1966-) (orvos-epidemiológus) Kovács Nóra (1989-) (népegészségügyi szakember) Seres Ildikó (1954-) (biokémikus) Paragh György (1953-) (belgyógyász) Ádány Róza (1952-) (megelőző orvostan és népegészségtan szakorvos)
Pályázati támogatás:GINOP-2.3.2-15-2016-00005
GINOP
135784
OTKA
TK2016-78
Egyéb
TKCS-2021/32
Egyéb
ÚNKP-22-4-II-DE-268
Egyéb
RRF-2.3.1-21-2022-00006
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.